CSPCY (CSPC Pharmaceutical Group) Dividend Payout Ratio: 12.17 (As of Dec. 2025) — 4097% Above Median


CSPCY CSPC Pharmaceutical Group Ltd CSPCY
76 GF Score
Price $3.58
GF Value $3.37
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Dividend Payout Ratio?

CSPC Pharmaceutical Group CSPCY +9.27% 76 Dividend Payout Ratio is 12.17 as of Dec. 2025, which is 4097% above its 10-year median of 0.29. GuruFocus rates CSPCY with a GF Score™ of 76/100 and a GF Value™ of $3.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 444 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks worse than 85.36% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. CSPC Pharmaceutical Group's Dividend Payout Ratio for the months ended in Dec. 2025 was 12.17.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of CSPC Pharmaceutical Group Ltd is 0.83, which seems too high.

The historical rank and industry rank for CSPC Pharmaceutical Group's Dividend Payout Ratio or its related term are showing as below:

CSPCY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0   Med: 0.29   Max: 0.83
Current: 0.83

During the past 13 years, the highest Dividend Payout Ratio of CSPC Pharmaceutical Group was 0.83. The lowest was 0.00. And the median was 0.29.

CSPCY's Dividend Payout Ratio is ranked worse than
85.36% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs CSPCY: 0.83

As of today (2026-06-30), the Dividend Yield % of CSPC Pharmaceutical Group is 4.15%.

During the past 13 years, the highest Trailing Annual Dividend Yield of CSPC Pharmaceutical Group was 6.70%. The lowest was 0.48%. And the median was 1.55%.

CSPC Pharmaceutical Group's Dividends per Share for the months ended in Dec. 2025 was $0.07.

During the past 12 months, CSPC Pharmaceutical Group's average Dividends Per Share Growth Rate was -16.80% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 21.40% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CSPC Pharmaceutical Group was 70.10% per year. The lowest was -31.00% per year. And the median was 15.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

CSPC Pharmaceutical Group (OTCPK:CSPCY) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

CSPC Pharmaceutical Group Dividend Payout Ratio Related Terms

CSPC Pharmaceutical Group Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Dividend Payout Ratio Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.35 0.00 0.01 0.69

CSPC Pharmaceutical Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.98 0.00 12.17 0.00

CSPCY vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Dividend Payout Ratio falls into.


CSPCY
76GF Score
CSPC Pharmaceutical Group Ltd CSPCY
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

CSPC Pharmaceutical Group's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.125/ 0.18
=0.69

CSPC Pharmaceutical Group's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0.073/ 0.006
=12.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 12.17 mean?
CSPC Pharmaceutical Group (CSPCY) has a Dividend Payout Ratio of 12.17 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on CSPC Pharmaceutical Group and its competitors. This is 4097% above median its historical median of 0.29. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #379 out of 444 companies in the Drug Manufacturers industry, placing it in the top 85.4%.
Is CSPC Pharmaceutical Group's Dividend Payout Ratio too high?
CSPC Pharmaceutical Group's current Dividend Payout Ratio of 12.17 is 4097% above median its 10-year median of 0.29. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. CSPC Pharmaceutical Group's value of 12.17 is 3145.3% above this industry median. Based on the distribution chart, CSPC Pharmaceutical Group ranks #379 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, CSPC Pharmaceutical Group has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #379 out of 444 companies for Dividend Payout Ratio. This places CSPC Pharmaceutical Group in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. CSPC Pharmaceutical Group's value of 12.17 is 3145.3% above this benchmark. While the company's 10-year median is 0.29 vs. the industry median of 0.38, CSPC Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSPC Pharmaceutical Group's current Dividend Payout Ratio of 12.17 is 3145.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current Dividend Payout Ratio is 12.17, which is 4097% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Fairly Valued. The stock's GF Value™ is $3.37, compared to a current price of $3.58 — trading 6.4% above its estimated fair value. The current Dividend Payout Ratio is 12.17, which is 4097% above median its 10-year median of 0.29 and 3145.3% above the Drug Manufacturers industry median of 0.38. CSPC Pharmaceutical Group's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Dividend Payout Ratio is 12.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of $3.58 is trading 6.4% above its estimated GF Value™ of $3.37. GuruFocus considers CSPC Pharmaceutical Group to be Fairly Valued.

Key valuation signals for CSPCY:

  • Dividend Payout Ratio: 12.17 (4097% above median its 10-year median of 0.29)
  • GF Value™: $3.37 vs. price of $3.58 (6.4% above fair value)
  • GF Score™: 76/100 with 4 warning signs
  • Industry Position: 3145.3% above the Drug Manufacturers median (#379 of 444)

No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
76GF Score

Get the complete analysis for CSPCY

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.58
Price
$3.37
GF Value